Physician
General Surgery
Dr. George E. Peoples Jr., MD
|
|
Give Review
George E. Peoples Jr. works in the field of General Surgery. He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care He received awards:"Fellow (FACS)". George Peoples is a published physician as well. He has 71 publications published. The latest was: Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
Publications
- Adjuvant HER2/neu peptide cancer vaccines in breast cancer.
- Novel dendritic cell-based vaccination in late stage melanoma.
- Time-dependent Estimates of Recurrence and Survival in Colon Cancer: Clinical Decision Support System Tool Development for Adjuvant Therapy and Oncological Outcome Ass...
- The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response.
- Impact of margin status and local recurrence on soft-tissue sarcoma outcomes.
- Rethinking cancer vaccines to avoid T-cell traps.
- Technical Effects of Adding 1 % Lidocaine to Technetium Sulfur Colloid for Sentinel Lymphatic Mapping in Early Breast Cancer: Analysis of Data from a Double-blind Rand...
- Clinical decision support and individualized prediction of survival in colon cancer: bayesian belief network model.
- Time-Dependent Trends in Lymph Node Yield and Impact on Adjuvant Therapy Decisions in Colon Cancer Surgery: An International Multi-Institutional Study.
- United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with stand...
- The GP2 peptide: A HER2/neu-based breast cancer vaccine.
- Thyroid Cancer Incidence among Active Duty U.S. Military Personnel, 1990-2004.
- Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: From US Military Cancer Institute Clinical Trials Grou...
- Standardized pretreatment breast MRI-accuracy and influence on mastectomy decisions.
- The Impact of Age on Quality Measure Adherence in Colon Cancer.
- Colorectal, prostate, and skin cancer screening among Hispanic and White non-Hispanic men, 2000-2005.
- Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and...
- Folate receptor α: A storied past and promising future in immunotherapy.
- Trends in cancer screening among Hispanic and white non-Hispanic women, 2000-2005.
- Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prosp...
- A new era in anticancer peptide vaccines.
- Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial.
- Predictive model of outcome of targeted nodal assessment in colorectal cancer.
- Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clin...
- Development of a Bayesian classifier for breast cancer risk stratification: a feasibility study.
- HER2 vaccination in high-risk breast cancer.
- Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy?
- Cancer incidence in the U.S. military population: comparison with rates from the SEER program.
- The impact of HER2/neu expression level on response to the E75 vaccine: from U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
- Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005.
- Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury.
- Overcoming cancer immune tolerance and escape.
- Longterm followup assessment of a HER2/neu peptide (E75) vaccine for prevention of recurrence in high-risk prostate cancer patients.
- Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01...
- Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.
- Prospective trial evaluating electrical impedance scanning of thyroid nodules before thyroidectomy: final results.
- Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinic...
- Breast cancer screening compliance among young women in a free access healthcare system.
- Quantification and phenotypic characterization of circulating tumor cells for monitoring response to a preventive HER2/neu vaccine-based immunotherapy for breast cance...
- Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study.
- Breast cancer vaccines: promise for the future or pipe dream?
- Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United S...
- Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
- Responding to challenges in modern combat casualty care: innovative use of advanced regional anesthesia.
- Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial.
- A novel device developed, tested, and used for warming and maintaining intravenous fluids in a forward surgical team during Operation Enduring Freedom.
- Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer.
- Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients.
- Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients.
- Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients.
- Colon sentinel lymph node mapping: practical surgical applications.
- The 274th Forward Surgical Team experience during Operation Enduring Freedom.
- Combat casualties in Afghanistan cared for by a single Forward Surgical Team during the initial phases of Operation Enduring Freedom.
- Sensitivity of undifferentiated, high-TCR density CD8+ cells to methylene groups appended to tumor antigen determines their differentiation or death.
- Electrical impedance scanning of thyroid nodules before thyroid surgery: a prospective study.
- The most frequently requested precombat refresher training by the Special Forces medics during Operation Enduring Freedom.
- Caring for the wounded in Iraq--a photo essay.
- Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cance...
- Presentations from the Walter Reed Army Medical Center. Case 2: a mass in the head of the pancreas.
- Presentations from the Walter Reed Army Medical Center. Case 1: rectal carcinoma.
- Clinical studies of vaccines targeting breast cancer.
- Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.
- A massive intra-abdominal lipomatous neoplasm arising from the bladder.
- Sentinel lymph node evaluation is technically feasible and may improve staging in colorectal cancer.
- The effect of changing gamma count threshold on sentinel lymph node accuracy.
- Special issue on current challenges and future directions in monitoring recurrence after treatment of primary cancer.
- Current Approaches and Challenges in Early Detection of Breast Cancer Recurrence.
- Future Directions for the Early Detection of Recurrent Breast Cancer.
- Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer.
- Special issue on current challenges and future directions in monitoring responses after treatment of primary cancer.
Schools
Johns Hopkins University School of Medicine
Doctors Specialties
- Complex General Surgical Oncology
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Brigham and Women's Hospital -
Johns Hopkins University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Anthony W. Braswell, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel F. McLaughlin, MD |
|
|
Dr. Michael C. Harnisch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy J. Vreeland, MD |
|
|
Dr. John D. Ritchie, MD |
|
|
Dr. John S. Berry IV, MD |
|
|
Dr. James A. Dickerson II, MD |
|
|
Dr. Julia M. Greene, MD |
|
|
Dr. Robert Houston IV, MD |
|
|
Dr. Mark O. Hardin, MD |
|
|
Dr. Timothy S. Park, MD |
|
|
Dr. Alan K. Sears, MD |
|
|
Dr. Kevin B. Waldrep, MD |
|
|
Dr. Grace E. Park, MD |
|
|
Dr. Ronald J. Khoury, MD
This Doctor is OpenDoctor Recommended.
|